[DPHARMA] QoQ TTM Result on 31-Mar-2012 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 2.94%
YoY- -6.7%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 135,311 132,969 140,215 141,205 138,132 137,291 134,988 0.15%
PBT 35,297 34,133 35,468 35,723 34,729 35,500 35,995 -1.29%
Tax -9,282 -7,787 -8,043 -8,233 -8,023 -6,509 -6,906 21.68%
NP 26,015 26,346 27,425 27,490 26,706 28,991 29,089 -7.14%
-
NP to SH 26,015 26,346 27,425 27,490 26,706 28,991 29,089 -7.14%
-
Tax Rate 26.30% 22.81% 22.68% 23.05% 23.10% 18.34% 19.19% -
Total Cost 109,296 106,623 112,790 113,715 111,426 108,300 105,899 2.11%
-
Net Worth 169,359 167,991 162,310 170,824 163,776 162,353 154,198 6.42%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 19,431 18,318 24,980 24,987 24,987 5,014 5,014 145.71%
Div Payout % 74.69% 69.53% 91.09% 90.90% 93.56% 17.30% 17.24% -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 169,359 167,991 162,310 170,824 163,776 162,353 154,198 6.42%
NOSH 138,819 138,836 138,727 138,881 138,793 138,763 138,917 -0.04%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 19.23% 19.81% 19.56% 19.47% 19.33% 21.12% 21.55% -
ROE 15.36% 15.68% 16.90% 16.09% 16.31% 17.86% 18.86% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 97.47 95.77 101.07 101.67 99.52 98.94 97.17 0.20%
EPS 18.74 18.98 19.77 19.79 19.24 20.89 20.94 -7.10%
DPS 14.00 13.20 18.00 18.00 18.00 3.61 3.61 145.82%
NAPS 1.22 1.21 1.17 1.23 1.18 1.17 1.11 6.47%
Adjusted Per Share Value based on latest NOSH - 138,881
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 14.07 13.82 14.58 14.68 14.36 14.27 14.03 0.18%
EPS 2.70 2.74 2.85 2.86 2.78 3.01 3.02 -7.16%
DPS 2.02 1.90 2.60 2.60 2.60 0.52 0.52 146.10%
NAPS 0.1761 0.1746 0.1687 0.1776 0.1703 0.1688 0.1603 6.43%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 2.13 2.36 2.23 2.40 2.02 2.10 2.34 -
P/RPS 2.19 2.46 2.21 2.36 2.03 2.12 2.41 -6.15%
P/EPS 11.37 12.44 11.28 12.13 10.50 10.05 11.17 1.18%
EY 8.80 8.04 8.87 8.25 9.53 9.95 8.95 -1.11%
DY 6.57 5.59 8.07 7.50 8.91 1.72 1.54 161.89%
P/NAPS 1.75 1.95 1.91 1.95 1.71 1.79 2.11 -11.67%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 -
Price 2.17 2.28 2.38 2.38 2.12 2.10 2.22 -
P/RPS 2.23 2.38 2.35 2.34 2.13 2.12 2.28 -1.46%
P/EPS 11.58 12.01 12.04 12.02 11.02 10.05 10.60 6.04%
EY 8.64 8.32 8.31 8.32 9.08 9.95 9.43 -5.64%
DY 6.45 5.79 7.56 7.56 8.49 1.72 1.63 149.13%
P/NAPS 1.78 1.88 2.03 1.93 1.80 1.79 2.00 -7.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment